https://www.mayo.edu/research/clinical-trials/cls-20391800?p=1
Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared...
open label study
https://cancer.ca/en/cancer-information/resources/glossary/o/openlabel-study
open-label study | Canadian Cancer Society
A type of clinical trial or research study in which both the participants and the researchers know what treatment the participants are receiving. Compare with...
open label studycanadiancancersociety
https://www.mayo.edu/research/clinical-trials/cls-20391800
Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared...
Learn more about services at Mayo Clinic.
open label study
https://investingnews.com/comp360-psilocybin-therapy-shows-potential-in-open-label-study-in-type-ii-bipolar-disorder-presented-at-acnp/
COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder...
Dec 8, 2022 - 12 out of 14 patients went into remission for three months following a single 25mg dose of COMP360 psilocybin therapy, in an independent...
open label study
https://www.semanticscholar.org/topic/Open-Label-Study/489073
Open Label Study | Semantic Scholar
A type of study that stipulates both the health provider and the subject be aware of the drug or treatment assignment.
open label studysemanticscholar
https://www.mayo.edu/research/clinical-trials/cls-20583569
An Open-label Study of XEN1101 in Epilepsy - Mayo Clinic
Learn more about services at Mayo Clinic.
open label studyxen1101epilepsymayoclinic
https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With...
Centanafadine (CTN) is a potential first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) currently in development for the treatment...
https://www.biospace.com/aurinia-announces-preliminary-topline-data-from-its-open-label-aurion-study-in-lupus-nephritis
Aurinia Announces Preliminary Topline Data From Its Open Label Aurion Study In Lupus Nephritis -...
https://www.seattlechildrens.org/research/research-studies-clinical-trials/current-studies/all/a-phase-3-prospective-open-label-multicenter-study-to-evaluate-the-safety-efficacy-and-pharmacokinetics-of-paricalcitol-oral-solution-for-the-treatment-of-secondary-hyperparathyroidism-in-pediatric-subjects-ages-0-to-9-years-with-stage-5-study00002090/
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and...
THis Phase 3 multi center study will evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution for the treatment of secondary...
https://www.seattlechildrens.org/research/research-studies-clinical-trials/current-studies/all/open-label-follow-up-study-of-the-pepites-study-to-evaluate-the-long-term-efficacy-and-safety-of-viaskin-peanut-people-study-study00000482/
OPEN-LABEL FOLLOW-UP STUDY OF THE PEPITES STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF...
To learn more about this study, please email the study team member listed below.